Home > Products > CD28 & HN
> Human Anti-CD28 x Anti-HN Bispecific Antibody (IgG-IgG)
Human Anti-CD28 x Anti-HN Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H235)
Anti-CD28 x Anti-HN Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD28 and anti-HN parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the tumor vaccine modification and the research of Tumors therapy.
There are currently no customer reviews or questions for Human Anti-CD28 x Anti-HN Bispecific Antibody (IgG-IgG) (BSIG-H235). Click the button below to contact us or submit your feedback about this product.